Drug intelligence / Profile preview

Baoerkang San

Development stage: Unknown
Lead developer: Hong Kong Kang En Tang Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Baoerkang San is a Traditional Chinese Medicine (TCM) powder developed by Hong Kong Kang En Tang Pharmaceutical Co., Ltd., specifically formulated for pediatric use. It is primarily indicated for the treatment of pediatric dietetic diarrhea and indigestion, conditions often characterized by abdominal pain, bloating, and irregular bowel movements resulting from food stagnation. The preparation works by harmonizing the stomach and strengthening the spleen's transportive function, facilitating the breakdown and absorption of nutrients while alleviating gastrointestinal distress. As a multi-herb formulation, it contains various natural active compounds that collectively regulate digestive motility and improve appetite in children.

Brand names: Baoerkang San
Other names: 保儿康散

Beyond the preview

Go deeper on Baoerkang San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baoerkang San.

Explore the full profile